These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 6401999)

  • 1. Effects of dazoxiben and low-dose aspirin on platelet behaviour in man.
    Jones EW; Cockbill SR; Cowley AJ; Hanley SP; Heptinstall S
    Br J Clin Pharmacol; 1983; 15 Suppl 1(Suppl 1):39S-44S. PubMed ID: 6401999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human blood platelet behaviour after inhibition of thromboxane synthetase.
    Heptinstall S; Fox SC
    Br J Clin Pharmacol; 1983; 15 Suppl 1(Suppl 1):31S-37S. PubMed ID: 6401998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of dazoxiben, an inhibitor of thromboxane synthetase, on cold-induced forearm vasoconstriction and platelet behaviour in different individuals.
    Cowley AJ; Jones EW; Carter AJ; Hanley SP; Heptinstall S
    Br J Clin Pharmacol; 1985 Jan; 19(1):1-8. PubMed ID: 2983748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thromboxane (Tx) A2 receptor blockade and TxA2 synthase inhibition alone and in combination: comparison of anti-aggregatory efficacy in human platelets.
    Watts IS; Wharton KA; White BP; Lumley P
    Br J Pharmacol; 1991 Feb; 102(2):497-505. PubMed ID: 1826620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of thromboxane synthetase inhibition on arachidonate metabolism and platelet behaviour.
    Parry MJ
    Br J Clin Pharmacol; 1983; 15 Suppl 1(Suppl 1):23S-29S. PubMed ID: 6401997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of a thromboxane synthetase inhibitor and a cAMP phosphodiesterase inhibitor, singly and in combination, on platelet behaviour.
    Sills T; Heptinstall S
    Thromb Haemost; 1986 Jun; 55(3):305-8. PubMed ID: 3018954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of a thromboxane synthetase inhibitor, dazoxiben, and acetylsalicylic acid on platelet function and prostaglandin metabolism.
    Dale J; Thaulow E; Myhre E; Parry J
    Thromb Haemost; 1983 Oct; 50(3):703-6. PubMed ID: 6689091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aspirin and dazoxiben as inhibitors of platelet behaviour: modification of their effects by agents that alter cAMP production.
    Sills T; Cowley AJ; Heptinstall S
    Thromb Res; 1986 Apr; 42(1):91-8. PubMed ID: 3010495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet aggregation in whole blood: the role of thromboxane A2 and adenosine diphosphate.
    Carter AJ; Heptinstall S
    Thromb Haemost; 1985 Oct; 54(3):612-6. PubMed ID: 3937261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum albumin enhances the impairment of platelet aggregation with thromboxane synthase inhibition by increasing the formation of prostaglandin D2.
    Gresele P; Deckmyn H; Huybrechts E; Vermylen J
    Biochem Pharmacol; 1984 Jul; 33(13):2083-8. PubMed ID: 6430299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of dazoxiben on platelet-vessel wall interaction.
    Davies JA; Menys VC
    Br J Clin Pharmacol; 1983; 15 Suppl 1(Suppl 1):45S-46S. PubMed ID: 6681703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacologic inhibition of thromboxane synthetase and platelet aggregation: modulatory role of cyclooxygenase products.
    Bertelé V; Falanga A; Tomasiak M; Chiabrando C; Cerletti C; de Gaetano G
    Blood; 1984 Jun; 63(6):1460-6. PubMed ID: 6426554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute arterial thrombosis in rabbits: reduced platelet accumulation after treatment with dazoxiben hydrochloride (UK 37,248-01).
    Randall MJ; Wilding RI
    Br J Clin Pharmacol; 1983; 15 Suppl 1(Suppl 1):49S-55S. PubMed ID: 6687429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of the thromboxane synthetase inhibitor UK-37,248 (dazoxiben) upon platelet aggregation, coronary artery thrombosis and vascular reactivity.
    Schumacher WA; Lucchesi BR
    J Pharmacol Exp Ther; 1983 Dec; 227(3):790-6. PubMed ID: 6418881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of arachidonate-induced human platelet aggregation by a single low oral dose of aspirin in combination with a thromboxane synthase inhibitor.
    Cerletti C; Rajtar G; Bertelé V; de Gaetano G
    Thromb Haemost; 1984 Oct; 52(2):215. PubMed ID: 6441306
    [No Abstract]   [Full Text] [Related]  

  • 16. SQ 22536, an adenylate-cyclase inhibitor, prevents the antiplatelet effect of dazoxiben, a thromboxane-synthetase inhibitor.
    Bertelé V; Falanga A; Tomasiak M; Cerletti C; de Gaetano G
    Thromb Haemost; 1984 Feb; 51(1):125-8. PubMed ID: 6326343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet thromboxane synthetase inhibitors with low doses of aspirin: possible resolution of the "aspirin dilemma".
    Bertelé V; Falanga A; Tomasiak M; Dejana E; Cerletti C; de Gaetano G
    Science; 1983 Apr; 220(4596):517-9. PubMed ID: 6682245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thromboxane synthase inhibition potentiates washed platelet activation by endogenous and exogenous arachidonic acid.
    Patscheke H
    Biochem Pharmacol; 1985 Apr; 34(8):1151-6. PubMed ID: 3922373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dazoxiben examined for platelet inhibitory effect in an artificial circulation.
    Goldman M; Hall C; Hawker RJ; McCollum CN
    Br J Clin Pharmacol; 1983; 15 Suppl 1(Suppl 1):61S-65S. PubMed ID: 6681706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of dazoxiben, an inhibitor of thromboxane synthetase, on forearm vasoconstriction in response to cold stimulation, and on human blood vessel prostacyclin production.
    Cowley AJ; Jones EW; Hanley SP
    Br J Clin Pharmacol; 1983; 15 Suppl 1(Suppl 1):107S-112S. PubMed ID: 6337600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.